183 related articles for article (PubMed ID: 6753887)
1. A placebo-controlled study to determine the efficacy of oral disopyramide phosphate for the prophylaxis of ventricular dysrhythmias after acute myocardial infarction.
Kumana CR; Rambihar VS; Tanser PH; Cairns JA; Gupta RN; Wildeman RA; Johnston M; Johnson AL; Gent M
Br J Clin Pharmacol; 1982 Oct; 14(4):519-27. PubMed ID: 6753887
[TBL] [Abstract][Full Text] [Related]
2. Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction.
Jennings G; Jones MS; Besterman EM; Model DG; Turner PP; Kidner PH
Lancet; 1976 Jan; 1(7950):51-4. PubMed ID: 54578
[TBL] [Abstract][Full Text] [Related]
3. Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards.
Zainal N; Carmichael DJ; Griffiths JW; Besterman EM; Kidner PH; Gillham AD; Summers GD
Lancet; 1977 Oct; 2(8044):887-9. PubMed ID: 72237
[TBL] [Abstract][Full Text] [Related]
4. Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction.
Pouleur H; Chaudron JM; Reyns P
Eur J Cardiol; 1977 Jul; 5(5):397-404. PubMed ID: 330168
[TBL] [Abstract][Full Text] [Related]
5. Disopyramide--an effective treatment for lignocaine resistant ventricular dysrhythmias.
Green AG
Scott Med J; 1979 Jan; 24(1):21-4. PubMed ID: 91197
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide.
Allen-Narker RA; Roberts CJ; Marshall AJ; Jordan SC; Barritt DW; Goodfellow RM
Br J Clin Pharmacol; 1984 Nov; 18(5):725-32. PubMed ID: 6439233
[TBL] [Abstract][Full Text] [Related]
7. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction.
Rønnevik PK; Gundersen T; Abrahamsen AM
Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718
[TBL] [Abstract][Full Text] [Related]
8. Acute intervention studies in patients with myocardial infarction using atenolol, propranolol, oxprenolol and disopyramide phosphate.
Wilcox RG
Acta Med Scand Suppl; 1981; 651():193-202. PubMed ID: 6119875
[TBL] [Abstract][Full Text] [Related]
9. Absorption and antidysrhythmic activity of oral disopyramide phosphate after acute myocardial infarction.
Kumana CR; Rambihar VS; Willis K; Gupta RN; Tanser PH; Cairns JA; Wildeman RA; Johnston M; Johnson AL; Gent M
Br J Clin Pharmacol; 1982 Oct; 14(4):529-37. PubMed ID: 6753888
[No Abstract] [Full Text] [Related]
10. Studies on the preventive method of lowered ventricular fibrillation threshold during experimental acute myocardial infarctions. A comparison between disopyramide phosphate and lidocaine.
Hori Y; Okamoto R; Hatani M; Imai N; Toh H; Takano S; Nadai T; Fukuzaki H
Jpn Heart J; 1981 Sep; 22(5):801-13. PubMed ID: 7321204
[TBL] [Abstract][Full Text] [Related]
11. Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study.
Naccarella F; Bracchetti D; Palmieri M; Cantelli I; Bertaccini P; Ambrosioni E
Am Heart J; 1985 Apr; 109(4):833-40. PubMed ID: 3885700
[TBL] [Abstract][Full Text] [Related]
12. Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction.
Wilcox RG; Rowley JM; Hampton JR; Mitchell JR; Roland JM; Banks DC
Lancet; 1980 Oct; 2(8198):765-9. PubMed ID: 6107452
[TBL] [Abstract][Full Text] [Related]
13. [Disopyramide and lignocaine in the treatment of ventricular arrhythmia in patients with acute ischemic heart disease].
Pedersen-Bjergaard O; Lindeneg O; Svendsen TL; Enk B; Fridberg M
Ugeskr Laeger; 1986 May; 148(22):1349-51. PubMed ID: 3523916
[No Abstract] [Full Text] [Related]
14. Prophylactic disopysramide: its clinical effects related to plasma concentration in myocardial infarction.
Hillson RM; Boyd E; Cunningham J
J Int Med Res; 1980; 8(5):314-20. PubMed ID: 6998791
[No Abstract] [Full Text] [Related]
15. Intravenous and oral disopyramide after myocardial infarction.
Nicholls DP; Haybyrne T; Barnes PC
Lancet; 1980 Nov; 2(8201):936-8. PubMed ID: 6107587
[TBL] [Abstract][Full Text] [Related]
16. Prajmalium bitartrate in chronic ventricular arrhythmias: comparison with disopyramide.
Chiariello M; Indolfi C; Cappelli Bigazzi M; Condorelli M
Eur J Clin Pharmacol; 1983; 24(1):35-9. PubMed ID: 6832199
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, parallel group comparison of disopyramide phosphate and quinidine in patients with cardiac arrhythmias.
Arif M; Laidlaw JC; Oshrain C; Willis PW; Nissen CH; McDermott DJ; Smith WS; Karim A; Wilson RR
Angiology; 1983 Jun; 34(6):393-400. PubMed ID: 6408949
[TBL] [Abstract][Full Text] [Related]
18. [Preventive disopyramide in patients with ventricular arrhythmias detected by exercise].
Cardonne A; Pérez-Medina T; García-Barreto D
Arch Inst Cardiol Mex; 1976; 46(1):69-73. PubMed ID: 779692
[TBL] [Abstract][Full Text] [Related]
19. Acute oral antiarrhythmic testing with disopyramide.
García-Barreto D; Toruncha A; Gonzalez-Gomez A; Llerena L; Groning E; Hernandez-Cañero A
Clin Cardiol; 1981; 4(6):330-5. PubMed ID: 7326884
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of encainide and disopyramide in chronic ventricular arrhythmias: a double-blind placebo-controlled crossover study.
Caron JF; Libersa CC; Kher AR; Kacet S; Wanszelbaum H; Dupuis BA; Poirier JM; Lekieffre JP
J Am Coll Cardiol; 1985 Jun; 5(6):1457-63. PubMed ID: 2582017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
